[Growth hormone response to insulin-induced hypoglycaemia in children with normal stature or normal variant short

Insights

Establishing normal growth hormone (GH) levels in children is crucial for diagnosing deficiencies. This study defines normal GH responses to insulin-induced hypoglycemia in pre-pubertal children, aiding in accurate diagnosis.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Physiology
  • Diagnostic Endocrinology

Context:

  • Accurate assessment of growth hormone (GH) secretion is vital for diagnosing growth disorders in children.
  • Insulin-induced hypoglycemia is a standard provocative test for evaluating GH secretion.
  • Defining normal GH values is essential for differentiating between normal variant short stature and pathological conditions.

Purpose:

  • To establish normal reference values for growth hormone (GH) levels during insulin-induced hypoglycemia in pre-pubertal children.
  • To compare GH responses to insulin-induced hypoglycemia with nocturnal GH secretion.
  • To determine the lower limit of normal GH response that excludes GH deficiency.

Summary:

  • A study involving 30 pre-pubertal children (aged 6.4-16.8 years) with normal or short stature assessed maximal GH levels during insulin-induced hypoglycemia and 12-hour nocturnal GH secretion.
  • A GH response exceeding 20 mIU/L (10 ng/mL) to insulin-induced hypoglycemia was identified as the lower limit of the normal range, excluding GH deficiency.
  • GH responses between 15-20 mIU/L during insulin-induced hypoglycemia were also frequently indicative of normal endogenous GH secretion in short, normal children.

Impact:

  • Provides crucial reference ranges for diagnosing growth hormone deficiency in pediatric populations.
  • Enhances the accuracy of diagnostic protocols for short stature in children.
  • Contributes to better clinical decision-making regarding growth hormone therapy.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...